BioSpecifics Reports First Quarter 2020 Financial and Operating Results
- Monday, May 11, 2020, 7:14
- Business
- Add a comment
WILIMINGTON, Del., May 11, 2020 /PRNewswire/ — BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX® in North America, today…
About the Author
adminasapcorp has written 41552 stories on this site.